Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Sets New 1-Year High – Still a Buy?

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF)’s share price reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as $52.25 and last traded at $52.25, with a volume of 0 shares trading hands. The stock had previously closed at $52.25.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Royal Bank of Canada raised shares of Recordati Industria Chimica e Farmaceutica to a “hold” rating in a research note on Monday, October 7th. Barclays upgraded Recordati Industria Chimica e Farmaceutica to a “strong sell” rating in a research note on Tuesday, October 22nd.

Recordati Industria Chimica e Farmaceutica Price Performance

The company has a fifty day moving average price of $52.21 and a 200 day moving average price of $52.02. The company has a current ratio of 1.36, a quick ratio of 0.95 and a debt-to-equity ratio of 0.73.

Recordati Industria Chimica e Farmaceutica Company Profile

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.